Cumberland Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 08/14/2026 | 503.15 K | $3.26 M | -9.04% | 3.36% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 478.26 K | $3.10 M | 1.61% | 3.19% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 379.48 K | $2.46 M | 4.90% | 2.53% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 233.31 K | $1.51 M | -15.58% | 1.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 200.70 K | $1.30 M | 253.97% | 1.34% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 112.54 K | $729.29 K | -11.86% | 0.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 108.41 K | $702.62 K | -5.14% | 0.72% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 96.98 K | $628.44 K | -50.77% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 79.70 K | $516.46 K | 374.40% | 0.53% |
| CITADEL ADVISORS LLC | 09/02/2026 | 73.39 K | $475.57 K | 340.97% | 0.49% |
| BLACKROCK, INC. | 08/07/2026 | 63.55 K | $411.79 K | 11.70% | 0.42% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 58.46 K | $378.81 K | 0.00% | 0.39% |
| JANE STREET GROUP, LLC | 08/14/2026 | 56.74 K | $367.68 K | 288.45% | 0.38% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 54.91 K | $355.81 K | 20.35% | 0.37% |
| STATE STREET CORP | 09/22/2026 | 39.51 K | $256.03 K | 0.00% | 0.26% |
| JANE STREET GROUP, LLC | 08/14/2026 | 33.70 K | $218.38 K | 6.98% | 0.22% |
| UBS GROUP AG | 08/13/2026 | 26.34 K | $170.68 K | 407.59% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 26.20 K | $169.78 K | -83.97% | 0.17% |
| BAILARD, INC. | 07/30/2026 | 24.62 K | $159.56 K | 100.00% | 0.16% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 24.01 K | $155.61 K | 100.00% | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 23.98 K | $155.40 K | 116.34% | 0.16% |
| CITADEL ADVISORS LLC | 09/02/2026 | 23.10 K | $149.69 K | 84.80% | 0.15% |
| NORTHERN TRUST CORP | 08/13/2026 | 21.95 K | $142.26 K | 11.99% | 0.15% |
| JANE STREET GROUP, LLC | 08/14/2026 | 21.20 K | $137.38 K | 65.63% | 0.14% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 20.25 K | $131.23 K | 0.00% | 0.14% |
| CRESSET ASSET MANAGEMENT, LLC | 08/14/2026 | 19.48 K | $126.20 K | 0.00% | 0.13% |
| XTX TOPCO LTD | 08/14/2026 | 14.12 K | $91.49 K | -41.19% | 0.09% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 4.54 K | $29.45 K | 100.00% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 3.26 K | $21.13 K | 0.03% | 0.02% |
| CAPITAL ADVISORS, LTD. LLC | 07/16/2026 | 437 | $3.00 K | 0.00% | 0.00% |
| INSTITUTE FOR WEALTH MANAGEMENT, LLC. | 07/28/2026 | 352 | $2.29 K | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 200 | $1.30 K | 100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 191 | $1.24 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 100 | $648 | 0.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 48 | $311 | 100.00% | 0.00% |
| FMR LLC | 08/13/2026 | 21 | $136 | 100.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 08/13/2026 | 1 | $6 | 0.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| J. GOLDMAN & CO LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
| MAREX GROUP PLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cumberland Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 50 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 503,153
RENAISSANCE TECHNOLOGIES LLC: 478,263
VANGUARD CAPITAL MANAGEMENT LLC: 379,478
DIMENSIONAL FUND ADVISORS LP: 233,305
BOOTHBAY FUND MANAGEMENT, LLC: 112,544
GEODE CAPITAL MANAGEMENT, LLC: 108,413
16.48% of Cumberland Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.46 M shares in the last 24 months. This purchase volume represents approximately $11.79 M in transactions.